J.P. Morgan - U.S. Major and Specialty PharmaceuticalsArmed with Ph. 2b NMIBC interim data @3-month, fall/winter healthcare conferences will offer additional visibility for or following an uplisting to the NASDAQ.
@
2020 38th JP Morgan Halthcare conference (Jan 13-16 2020)
there will be key people like this one:
Chris Schott Managing Director and Senior Analyst, U.S. Major and Specialty Pharmaceuticals, J.P. Morgan